What does GlycoMimetics Inc’s (NASDAQ:GLYC) abstract data for the American Society for Clinical Oncology (ASCO) bring to the table for acute myeloid leukemia …
How does investor sentiment rise and fall for Apple Inc. (NASDAQ:AAPL) and Advanced Micro Devices, Inc.
In a research report released on Wednesday, Rosenblatt analyst Jun Zhang initiated coverage on shares of Oclaro, Inc. (NASDAQ:OCLR), with a Buy rating …
Drug maker Sophiris Bio Inc (NASDAQ:SPHS) released its earnings report for the first quarter of 2017 and is one step closer to beginning Phase …
Believing Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) odds in the IBS-C competitive arena just got better, Rodman & Renshaw analyst Ram Selvaraju reiterates a Buy …
Oppenheimer and one of the best analysts on the Street at RBC Capital are out with conviction backing two of the e-commerce universe’s …
On May 12th, Ardelyx Inc (NASDAQ:ARDX) shares plummeted 39%, quite a stark drop. The cause: a disappointing read-out of the first of two …
Beckoning fresh ambition and momentum, Apple Inc. (NASDAQ:AAPL) seems at an advantage to take a gamble with its priciest iPhone to date, and …
Synthetic Biologics Inc (NYSEMKT:SYN) shares were rising almost 29% yesterday as the news took off that the biotech firm won a Breakthrough Therapy …
Drug maker Omeros Corporation (NASDAQ:OMER) delivered solid results for its earnings report for the first quarter of the year 2017. In reaction, Maxim analyst Jason …
